Details
LaproNext Indications
Reduction of increased intraocular pressure in patients with open-angle glaucoma and increased intraocular pressure.
Reduction of high intraocular pressure in pediatric patients with high intraocular pressure and pediatric glaucoma.
Contradictions
Hypersensitivity to any component of the drug LaproNext is known.
Dosage & Administration
The recommended dose is for adults, including the elderly
Recommended therapy: 1 drop in the affected eye (eyes) 1 time per day. The optimal effect is achieved when using the drug LaproNext in the evening.
The drug should not be used more than once a day, as it is shown that more frequent use reduces the effectiveness of reducing intraocular pressure.
If a dose is missed, treatment should be continued by taking the next dose at the usual time.
As with any eye drops, it is recommended to compress the lacrimal sac in the area of the medial corner of the eye (occlusion of the lacrimal points) for 1 minute to reduce possible systemic absorption during instillation. This should be done immediately after instilling each drop.
Before instilling eye drops, contact lenses should be removed, they can be installed again in 15 minutes.
When using several ophthalmic agents of local action, the drugs should be used with an interval of at least 5 minutes.
Children. LaproNext eye drops can be used in pediatric patients with the same dosage as adults.
Data on the efficacy and safety of the drug in the age group up to 1 year are very limited (4 patients) (see section "Pharmacological properties"). There are no available data on the use of premature infants (born before the 36th week of pregnancy).
In children from birth to 3 years of age, who suffer mainly from primary congenital glaucoma, surgery (eg, trabeculotomy / goniotomy) remains the first-line method.
Long-term safety of the drug in children has not been established.
You have no items to compare.